Clinical Trials in Alzheimer’s Disease - CTAD 2015
Cambridge Cognition will be attending 8th Clinical Trials in Alzheimer’s disease conference in Barcelona 5th-7th November joining worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer’s disease treatments.
With this year’s meeting focusing on trying to get the latest trials off the ground, and looking at overcoming the hurdles and speed the development of effective treatments, Dr Jenny Barnett, Director of Healthcare Innovation and Dr Kenton Zavitz, Director of Clinical Affairs will be attending to talk to attendees about how CANTAB Connect is helping to accelerate Alzheimer’s drug development with cloud-based cognitive assessment software for precise measurement of brain function.
Connect with Jenny and Kenton ahead of the meeting.
Find out more about using CANTAB in Alzheimer's drug development.